Clinical Trial Update: Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating lenacapavir intensification to disrupt HIV reservoirs in virologically suppressed people with HIV on antiretroviral therapy; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Lenacapavir (lenacapavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: RECRUITING